FactaeThe Factual News

Top Stories Focus Media

Monde
France
Régional
Politique
Guerre
Défense & Sécurité

Économie
Marchés
Énergie
Crypto

Tech
Intelligence artificielle
Informatique
Cybersécurité

Science
Santé
Écologie

Histoire
Culture
Sport
Droit
Éducation

Factae

The Factual News

The intelligence of the news. Multi-source, geolocated, synthesized.

Live

Live feed Scoops Immersive map

Explore

Trading Board Trends AI models AI tools Sources

Information

About Methodology RSS feed Contact Terms Privacy Legal Newsletter

© 2026 Factae. All rights reserved.

Analysts adjust recommendations for Nexans and Abivax | Factae

Analysts adjust recommendations for Nexans and Abivax

Barclays and Jefferies modify their advice on Nexans and Abivax.

Published 2sem·1 sourceNotable·updated 4j

Lire en français

≈ 14sSpeed

The fact

Nexans benefits from an upward revision of its price target.

These adjustments reflect sectoral outlooks in Europe.

🔗Click the link to read an article on the topic:

🧭Explore this topic

Paris France Nexans Abivax Barclays Jefferies #Nexans #Abivax #analystes #recommandations #Europe

What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.→

ParisWorld map →

Follow topic →

Auto-synthesis from 1 media source · identified on July 1, 2026

← Back to home

Discover

Read more

All marches →

Jefferies and Barclays raise targets on Abivax and Ab Science

3sem · 1 source marches

Orange and Euronext reassessed by banking analysts

4sem · 1 source marches

Analyst recommendations in Paris undergo adjustments

7sem · 1 source marches

CAC 40: Investors anticipate a technical correction

6j · 1 source marches

Analysts update recommendations on Paris-listed shares

5sem · 1 source marches

Nexans faces risk of stock correction below resistance levels

11sem · 1 source